WaveTec Vision Closes $15.9M Series D Financing
WaveTec Vision, an Aliso Viejo, CA-based developer of wavefront-guided Custom Cataract technology, has closed a $15.9m Series D financing.
The round was led by Versant Ventures, with participation from existing investors Accuitive Medical Ventures and De Novo Ventures and new backer Gund Investment Corporation.
The ORange® intraoperative wavefront aberrometer is a patented diagnostic system that allows cataract surgeons to measure refraction during surgery, so they can predict and customize how their patients will see following the procedure.
As stated by CEO Tom Frinzi, WaveTec intends to use the funds to expand commercialization and adoption of ORange, grow their infrastructure and further demonstrate its clinical efficacy.